Healx is a social enterprise passionate about finding new therapeutic solutions to cure patients with rare diseases. We use advanced data analytics, such as machine learning and computational chemo-biology to identify novel drug applications in the area of rare diseases. Healx is fortunate to be supported by an extensive network of advisors from the Cambridge biomedical cluster, one of the leading biotech clusters in the world.
Our approach offers great promise both for patients suffering from rare diseases and for biopharmaceutical companies wishing to make the most of their therapeutic portfolio.
Follow @healx on Twitter:
Find Healx on Facebook:
Access Healx’s LinkedIn company profile:
Watch Healx in discussion with Luther Phillips:
Watch a video on Healx’s work:
Visit the Healx website: